Announcement
Paiania, 22 November 2021 - Lavipharm S.A. announces, in accordance with Regulation 596/2014 / EU and the Regulation of the Athens Stock Exchange, each as in force, that Mr. Vassilis Baloumis assumes the duties of Chief Financial Officer on December 1, 2021 replacing Mr. Spyridon...
22 November, 2021